Browse Related Topics For:

Reverse Payment Settlement Agreements

76
FTC
68
FTC v Actavis
63
Patents
63
Pharmaceutical Industry
61
Generic Drugs
54
SCOTUS
39
Pay-For-Delay
35
ANDA
31
Hatch-Waxman
30
Actavis Inc.
24
Antitrust Litigation
24
Prescription Drugs
19
Patent Infringement
19
Pharmaceutical Patents
12
Anti-Competitive
11
FDA
11
Patent Litigation
11
Rule-of-Reason Analysis
10
EU
9
Competition
9
Sherman Act
8
European Commission
8
Settlement
7
Infringement
7
Watson Pharmaceuticals
6
DOJ
6
Patent-Eligible Subject Matter
6
Teva Pharmaceuticals
5
Antitrust Violations
5
CA Supreme Court
5
Cartels
5
Popular
4
AMP v Myriad
4
Cephalon
4
Human Genes
4
Patent Exhaustion
4
USPTO
3
Antitrust Injuries
3
Bowman v Monsanto
3
Cartwright Act
3
Cipro
3
Class Action
3
Copyright
3
Enforcement
3
Generic
3
Healthcare
3
Medicare
3
Monopolization
3
No-AG Agreement
3
Pleading Standards
3
Price-Fixing
3
Putative Class Actions
3
Standard Essential Patents
3
Unfair Competition
2
Acquisitions
2
Affordable Care Act
2
Amicus Briefs
2
Anticompetitive Agreements
2
Antitrust Investigations
2
Antitrust Provisions
2
Antitrust Standing
2
Arbitration
2
AstraZeneca
2
Bayer
2
Burden of Proof
2
Burden-Shifting
2
China
2
Class Certification
2
CMS
2
Corporate Counsel
2
Damages
2
Direct Purchasers
2
Disgorgement
2
Dismissals
2
DNA
2
Exclusivity
2
Expert Testimony
2
First Sale Doctrine
2
FRAND
2
FTC v. Phoebe Putney Health System
2
Genetically Engineered Seed
2
GlaxoSmithKline
2
Hospitals
2
Induced Infringement
2
IP License
2
Jurisdiction
2
Kirtsaeng v. John Wiley & Sons
2
Lanham Act
2
License Agreements
2
Lipitor
2
Manufacturers
2
Medicaid
2
Monsanto
2
Mylan Pharmaceuticals
2
Myriad
2
Nexium
2
Obviousness
2
Patent-Misuse
2
Penalties
2
Permanent Injunctions
2
Preemption
2
RanBaxy
2
Reverse Payments
2
Settlements
2
Takeda Pharmaceuticals
2
Warner Chilcott
1
Abuse of Dominance
1
ACCC
1
Acceleration
1
ACOs
1
Actos
1
Administrative Procedure Act
1
Advertising
1
Affirmative Action
1
Alien Tort Statute
1
Already LLC
1
Amended Regulation
1
America Invents Act
1
American Express
1
American Express v Italian Colors Restaurant
1
Amgen
1
Amgen Inc. v Connecticut Retirement Plans
1
Anti-Monopoly
1
Antibiotics
1
Antitrust Conspiracies
1
Antitrust Division
1
Apotex
1
Appeals
1
Apple
1
Apportionment
1
Arbitration Agreements
1
Attorney Generals
1
Attorney's Fees
1
Audits
1
Australia
1
Barclays
1
Benchmarks
1
Bifurcation
1
Biosimilars
1
BPCIA
1
Bullying
1
CAFA
1
Canning v NLRB
1
Causation
1
Certiorari
1
Claim Construction
1
Claims Limitations Period
1
Class Action Arbitration Waivers
1
Clear and Convincing Evidence
1
CLS Bank v Alice Corp
1
Coca Cola
1
Compliance
1
Computer-Related Inventions
1
Consent Order
1
Consideration
1
Contract Interpretation
1
Copyright Litigation
1
Counterclaims
1
Covenant Not to Sue
1
DaimlerChrysler
1
DaimlerChrysler v Bauman
1
Data Collection
1
Daubert Ruling
1
Dawn Raids
1
Deadlines
1
Declaratory Judgments
1
Diagnostic Method
1
Disclosure Requirements
1
Duty to Deal
1
Edith Ramirez
1
EEA
1
Endo Pharmaceuticals
1
Enforcement Actions
1
Equifax
1
Evidence
1
Exclusive Licenses
1
Extraterritoriality Rules
1
Failure To Warn
1
False Claims Act (FCA)
1
FDA Approval
1
FDCA
1
Federal Arbitration Act
1
Federal Rules of Civil Procedure
1
Financial Conduct Authority (FCA)
1
Financial Services Industry
1
Fines
1
Fisher v University of Texas
1
Forum
1
Forum Shopping
1
Fraud
1
Fraudulent Procurement
1
Gabelli v SEC
1
General Jurisdiction
1
Genetic Materials
1
Good Faith
1
Google
1
Health Insurance Exchanges
1
Hollingsworth v Perry
1
Hospital Mergers
1
Income Taxes
1
Inequitable Conduct
1
Injunctions
1
Injury-in-Fact
1
Innovation
1
Interest Rates
1
ITC
1
Johnson & Johnson
1
JPMorgan Chase
1
Labeling
1
Leave to Amend
1
Libor
1
Life Sciences
1
Market Abuse
1
Market-Sharing
1
MCOs
1
Means-Plus-Function
1
Medicare Modernization Act
1
Mergers
1
Microsoft
1
MiFID II
1
Motion for Reconsideration
1
Motion to Dismiss
1
Motion to Exclude
1
Motion To Stay
1
Mount Holly v Mt. Holly Citizens in Action
1
NC Board of Dental Examiners v FTC
1
New Regulations
1
New Trial
1
Nike
1
NLRB
1
Noerr-Pennington Doctrine
1
Non-Monetary Payments
1
Notice Requirements
1
Novartis
1
On-Sale Bar
1
Orange Book
1
Otsuka Pharmaceutical
1
Overpayment
1
Overpayment Recovery Time Limits
1
Oxford Health v Sutter
1
Patent Assertion Entities
1
Patent Invalidity
1
Patent Law Treaty
1
Patent Term Adjustment
1
Patent Trial and Appeal Board
1
Patent Validity
1
Pay-to-Delay System
1
Personal Jurisdiction
1
Pfizer
1
Pharmaceutical Distribution
1
PLIVA v Mensing
1
POM Wonderful
1
Post-Grant Review
1
Presumption of Validity
1
Prior Art
1
Private Right of Action
1
Product Hopping
1
Proposed Legislation
1
Public Use
1
REMS
1
Restraint of Trade
1
Retailers
1
Reversal
1
Safe Harbors
1
Same-Sex Marriage
1
Sandoz v Amgen
1
Sham Litigation Exception
1
SmithKline Beecham
1
Software
1
Solvency II
1
Specific Jurisdiction
1
Split of Authority
1
Standard Fire Ins. Co. v. Knowles
1
Standard of Proof
1
Standing
1
State Action Doctrine
1
State Aid
1
State Law Tort Claims
1
Statute of Limitations
1
Summary Judgment
1
Supervisors
1
Textbooks
1
Textiles
1
The Clayton Act
1
Trade Secrets
1
Trademarks
1
Twombly/Iqbal Pleading Standard
1
UBS
1
UK
1
Unified Patent Court
1
Unitary Patent
1
US v Windsor
1
UT Southwestern Medical v Nassar
1
Valuation
1
Vance v. Ball State University
1
Walker Process Claims
1
Wholesale
1
Willful Misconduct
1
Wireless Devices